Difference between revisions of "PMID:6264273"
(New PMID: Page!) |
(Table edited by Joncrz via TableEdit) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
+ | {{RightTOC}} | ||
+ | <!--box uid=d41d8cd98f00b204e9800998ecf8427e.3272.L5037f15058106--> | ||
+ | <!-- | ||
+ | ****************************************************************************************** | ||
+ | * | ||
+ | * ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | ||
+ | * | ||
+ | ****************************************************************************************** --> | ||
+ | {| id="L5037f15058106" class=" tableEdit PMID_info_table" | ||
+ | |||
+ | |- | ||
+ | !align=left |Citation | ||
+ | || | ||
+ | '''Ostrowski, J and Hulanicka, D''' (1981) Effect of DNA gyrase inhibitors on gene expression of the cysteine regulon.''Mol. Gen. Genet.'' '''181''':363-6 | ||
+ | |- | ||
+ | !align=left |Abstract | ||
+ | || | ||
+ | Nalidixic acid inhibits the expression of those cysteine genes which are regulated by the cysB product, it has no affect, however, on the constitutively-expressed cysE gene. The expression of cysteine genes in a strain carrying a mutation in the nalA locus is resistant to this drug. Novobiocin affects the expression of cysteine genes similarly to nalidixic acid. The effect of nalidixic acid on the expression of genes in a cysteine constitutive mutant was studied. | ||
+ | |- | ||
+ | !align=left |Links | ||
+ | || | ||
+ | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=6264273 PubMed] | ||
+ | |||
+ | |- | ||
+ | !align=left |Keywords | ||
+ | || | ||
+ | Acetyltransferases; Cysteine; Cysteine Synthase; Gene Expression Regulation; Genes, Regulator; Mutation; Nalidixic Acid; Novobiocin; Oxidoreductases Acting on Sulfur Group Donors; Salmonella typhimurium; Serine O-Acetyltransferase; Topoisomerase II Inhibitors | ||
+ | |||
+ | |- class="tableEdit_footer" | ||
+ | |<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.3272.L5037f15058106&page=3272&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> || | ||
+ | |} | ||
+ | <!--box uid=d41d8cd98f00b204e9800998ecf8427e.3272.L5037f15058106--> | ||
+ | |||
+ | ==Main Points of the Paper == | ||
+ | {{LitSignificance}} | ||
+ | |||
+ | == Materials and Methods Used == | ||
+ | {{LitMaterials}} | ||
+ | |||
+ | ==Phenotype Annotations== | ||
+ | {{AnnotationTableHelp}} | ||
+ | <protect><!--box uid=d41d8cd98f00b204e9800998ecf8427e.3272.M5037f15072af3--> | ||
+ | <!-- | ||
+ | ****************************************************************************************** | ||
+ | * | ||
+ | * ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | ||
+ | * | ||
+ | ****************************************************************************************** --> | ||
+ | {| border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; border: 1px #aaa solid; border-collapse: collapse;" id="M5037f15072af3" class=" tableEdit Phenotype_Table_2" | ||
+ | |- | ||
+ | !|Phenotype of!!Taxon Information!!Genotype Information (if known)!!Condition Information!!OMP ID!!OMP Term Name!!ECO ID!!ECO Term Name!!Notes!!Status | ||
+ | |- | ||
+ | | | ||
+ | a mutation or genetic difference within a strain | ||
+ | | | ||
+ | *Taxon: Escherichia coli | ||
+ | *Strain: K-12 | ||
+ | *Substrain: | ||
+ | *NCBI Taxon ID: [http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=83333&lvl=3&lin=f&keep=1&srchmode=1&unlock 83333] | ||
+ | | | ||
+ | *Genotype of Reference Strain: ''cysB'' | ||
+ | *Genotype of Experimental Strain : ''cys2332'' | ||
+ | | | ||
+ | *Reference Condition: | ||
+ | | | ||
+ | OMP:0000276 | ||
+ | | | ||
+ | increased resistance to antimicrobial compound | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Resistant to antibiotic nalidixic acid. | ||
+ | | | ||
+ | |||
+ | |||
+ | |- class="tableEdit_footer" | ||
+ | |<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.3272.M5037f15072af3&page=3272&pagename={{FULLPAGENAMEE}}&type=0&template=Phenotype_Table_2 edit table]</span> || || || || || || || || || | ||
+ | |} | ||
+ | <!--box uid=d41d8cd98f00b204e9800998ecf8427e.3272.M5037f15072af3--></protect> | ||
+ | |||
+ | ==Notes== | ||
+ | |||
+ | ==References== | ||
+ | {{RefHelp}} | ||
+ | <references/> | ||
+ | |||
+ | |||
+ | [[Category:Publication]] [[Category:Papers referenced in the LaRossa chapter]] [[Category:LaRossa citations that need review]] |
Latest revision as of 18:18, 23 January 2013
Citation |
Ostrowski, J and Hulanicka, D (1981) Effect of DNA gyrase inhibitors on gene expression of the cysteine regulon.Mol. Gen. Genet. 181:363-6 |
---|---|
Abstract |
Nalidixic acid inhibits the expression of those cysteine genes which are regulated by the cysB product, it has no affect, however, on the constitutively-expressed cysE gene. The expression of cysteine genes in a strain carrying a mutation in the nalA locus is resistant to this drug. Novobiocin affects the expression of cysteine genes similarly to nalidixic acid. The effect of nalidixic acid on the expression of genes in a cysteine constitutive mutant was studied. |
Links | |
Keywords |
Acetyltransferases; Cysteine; Cysteine Synthase; Gene Expression Regulation; Genes, Regulator; Mutation; Nalidixic Acid; Novobiocin; Oxidoreductases Acting on Sulfur Group Donors; Salmonella typhimurium; Serine O-Acetyltransferase; Topoisomerase II Inhibitors |
edit table |
Main Points of the Paper
Please summarize the main points of the paper.
Materials and Methods Used
Please list the materials and methods used in this paper (strains, plasmids, antibodies, etc).
Phenotype Annotations
See Help:AnnotationTable for details on how to edit this table.
<protect>
Phenotype of | Taxon Information | Genotype Information (if known) | Condition Information | OMP ID | OMP Term Name | ECO ID | ECO Term Name | Notes | Status |
---|---|---|---|---|---|---|---|---|---|
a mutation or genetic difference within a strain |
|
|
|
OMP:0000276 |
increased resistance to antimicrobial compound |
Resistant to antibiotic nalidixic acid. |
| ||
edit table |
</protect>
Notes
References
See Help:References for how to manage references in omp dev.